Transcutaneous magnetic cortical stimulation (TMS) for assessment of the external anal sphincter in neurogenic faecal incontinence

ISRCTN ISRCTN03140344
DOI https://doi.org/10.1186/ISRCTN03140344
Secondary identifying numbers N0226118468
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
29/07/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr ES Kiff
Scientific

Department of General Surgery
South Manchester University Hospitals NHS Trust
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
United Kingdom

Phone +44 (0)161 291 6654
Email Julie.Adger@smuht.nwest.nhs.uk

Study information

Study designRandomised, single-blinded, controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectives1. How do treatments for faecal incontinence have effect?
2. Does biofeedback have a neuroplastic cortical effect in patients with faecal incontinence?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedNervous System Diseases: Neurogenic faecal incontinence
InterventionPatients randomised to 1 of 3 groups, all will receive current biofeedback therapy, but at different time intervals:
1. Group 1 - Behaviour Modification - Baseline TMS - Behaviour Modification - TMS - Biofeedback - TMS
2. Group 2 - Biofeedback - Baseline TMS - Biofeedback - TMS
3. Group 3 - (Control) - Baseline TMS - repeat TMS - Biofeedback - TMS
Intervention typeOther
Primary outcome measureTo establish any cortical neuroplastic changes or nerve conduction changes in response to current treatments for faecal incontinence.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/10/2002
Completion date01/10/2004

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants45
Key inclusion criteria30 Patients over the age of 18 with neurogenic faecal incontinence will be recruited from the referrals to Mr ES Kiff and 15 controls.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/10/2002
Date of final enrolment01/10/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of General Surgery
Manchester
M23 9LT
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

South Manchester University Hospitals NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2005 Yes No